TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails May 25, 1979